Risk Of Offensive/Incorrect Content: Xyrem Approved for Use in Pediatric Patients With Narcolepsy

The article below may contain offensive and/or incorrect content.

Efficacy in the pediatric population with narcolepsy was demonstrated in the Phase 2/3 EXPRESS study (N=106) which included patients aged 7 to 17 years with narcolepsy with cataplexy.